Support clinical supply planning, label management, and distribution activities for global trials.
Coordinate with clinical, regulatory, quality, and external partners to ensure timely delivery of materials.
Assist with IRT system testing, supply strategy setup, and process improvement initiatives.
Jobgether is a recruitment platform that uses AI-powered matching to connect candidates with hiring companies. They focus on streamlining the application process and providing a collaborative work environment.
Lead commercial packaging engineering and ex-US manufacturing, managing CMOs and partners across international markets.
Own end-to-end artwork, serialization, and track-and-trace compliance, ensuring market-by-market alignment.
Drive packaging validation, budget management, and cross-functional collaboration to support launches and expansions.
BridgeBio is a biopharmaceutical company that pioneers a 'moneyball for biotech' model to develop life-changing medicines for unmet medical needs. They value curiosity, experimentation, and collaboration, bringing together respected experts across the industry.
Support and contribute to global regulatory strategies to expedite development and mitigate risks.
Plan, prepare, and coordinate regulatory documents for submissions to global health authorities (INDs, BLAs, MAAs, etc.).
Collaborate with cross-functional teams and support interactions with FDA and other Health Authorities.
Immunovant, Inc. is a clinical-stage immunology company developing targeted therapies for autoimmune diseases. As a rapid-growth biotech startup, it fosters a dynamic, fast-paced, and entrepreneurial environment.
Drive product commercialization activities within Supply Chain, ensuring flawless execution of Artwork milestones to support timely product launches.
Own the Supply Chain Change Control strategy and coordinate cross-functional impact assessments with Quality, Regulatory, and Manufacturing teams.
Support the creation and continuous improvement of the Product Variation Management process and maintain traceability between variations, change controls, and artwork updates.
BridgeBio is a biopharmaceutical company dedicated to discovering, developing, and delivering transformative medicines for patients with genetic diseases and genetically defined cancers. Since 2015, we have built a portfolio of over 20 drug development programs and achieved regulatory approval for three therapies, fostering a culture of curiosity, collaboration, and bold decision-making.
Own end-to-end supply chain, including co-manufacturer relationships, demand planning, inventory, logistics, and quality compliance.
Rebuild and scale supply chain operations to support rapid revenue growth, not just maintain existing processes.
Drive cost optimization, ERP implementation, and cross-functional coordination with marketing, growth, and finance.
Rosabella creates thoughtfully formulated supplements to support women's health during menopause and beyond. The company is a small, high-growth DTC brand with a lean team that values accountability, output, and direct feedback.
Provide strategic pharmaceutical development guidance as CMC lead to cross-functional project teams.
Develop robust formulations and manufacturing processes to support rapid registration of QED products.
Manage CRO relationships, drug forecasts, and regulatory submissions for clinical supply.
BridgeBio is a biotech company pioneering a 'moneyball for biotech' approach to reduce risk and accelerate development of life-changing medicines for rare diseases. They foster a culture of curiosity and experimentation, working alongside respected industry minds to reengineer the future of biopharma.
Create and execute clinical operational strategic plans aligned with product strategy and resource allocation.
Build, develop, and train internal staff and external vendors to enhance efficiency and engagement.
Oversee relationships with Contract Research Organizations, vendors, and investigative sites to ensure compliance with FDA and ICH GCP guidelines.
Lycia Therapeutics is a biotechnology company using its proprietary LYTAC platform to develop therapeutics that degrade extracellular and membrane-bound proteins. Founded in 2019, the company has raised $75 million in Series D financing and is headquartered in South San Francisco.